176 related articles for article (PubMed ID: 20932754)
21. Does one keto group matter? Structure-activity relationships of glycyrrhetinic acid derivatives modified at position C-11.
Csuk R; Schwarz S; Kluge R; Ströhl D
Arch Pharm (Weinheim); 2012 Jan; 345(1):28-32. PubMed ID: 22076975
[TBL] [Abstract][Full Text] [Related]
22. Novel 3'-Substituted-1',2',4'-Oxadiazole Derivatives of 18βH-Glycyrrhetinic Acid and Their
Markov AV; Sen'kova AV; Popadyuk II; Salomatina OV; Logashenko EB; Komarova NI; Ilyina AA; Salakhutdinov NF; Zenkova MA
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429154
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, anti-inflammatory, and antioxidant activities of 18beta-glycyrrhetinic acid derivatives as chemical mediators and xanthine oxidase inhibitors.
Maitraie D; Hung CF; Tu HY; Liou YT; Wei BL; Yang SC; Wang JP; Lin CN
Bioorg Med Chem; 2009 Apr; 17(7):2785-92. PubMed ID: 19278854
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of novel derivatives of gambogic acid as anti-hepatocellular carcinoma agents.
He L; Ling Y; Fu L; Yin D; Wang X; Zhang Y
Bioorg Med Chem Lett; 2012 Jan; 22(1):289-92. PubMed ID: 22153338
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity.
Massarico Serafim RA; Gonçalves JE; de Souza FP; de Melo Loureiro AP; Storpirtis S; Krogh R; Andricopulo AD; Dias LC; Ferreira EI
Eur J Med Chem; 2014 Jul; 82():418-25. PubMed ID: 24929292
[TBL] [Abstract][Full Text] [Related]
26. Anticancer drugs are synergistic with freezing in induction of apoptosis in HCC cells.
Yuan F; Zhou W; Zhang J; Zhang Z; Zou C; Huang L; Zhang Y; Dai Z
Cryobiology; 2008 Aug; 57(1):60-5. PubMed ID: 18586021
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and anti-hepatocellular carcinoma activity of novel O
Zou Y; Yan C; Liu JC; Huang ZJ; Xu JY; Zhou JP; Zhang HB; Zhang YH
Chin J Nat Med; 2017 Dec; 15(12):928-937. PubMed ID: 29329650
[TBL] [Abstract][Full Text] [Related]
28. [Novel hybrids of (phenylsulfonyl)furoxan and N-benzyl matrinol as anti-hepatocellular carcinoma agents].
He LQ; Yang Q; Wu YX; Wang XS
Yao Xue Xue Bao; 2015 May; 50(5):574-8. PubMed ID: 26234139
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives.
Li H; Wang K; Wan Q; Chen Y
Steroids; 2019 Jan; 141():81-95. PubMed ID: 30521816
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of novel furozan-based nitric oxide-releasing derivatives of oridonin as potential anti-tumor agents.
Li D; Wang L; Cai H; Zhang Y; Xu J
Molecules; 2012 Jun; 17(6):7556-68. PubMed ID: 22710829
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and Antiproliferative Activity of Novel Heterocyclic Glycyrrhetinic Acid Derivatives.
Alho DPS; Salvador JAR; Cascante M; Marin S
Molecules; 2019 Feb; 24(4):. PubMed ID: 30791593
[TBL] [Abstract][Full Text] [Related]
32. [Relationship between death receptor 5 and apoptosis in hepatocellular carcinoma].
Zhu RX; Lin JS; Song YH; Li PY; Tao LW
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):261-4. PubMed ID: 16875623
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic effects of cantharidin analogues without bridging ether oxygen on human hepatocellular carcinoma cells.
Yeh CB; Su CJ; Hwang JM; Chou MC
Eur J Med Chem; 2010 Sep; 45(9):3981-5. PubMed ID: 20691337
[TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo.
Nakamoto N; Higuchi H; Kanamori H; Kurita S; Tada S; Takaishi H; Toda K; Yamada T; Kumagai N; Saito H; Hibi T
Int J Oncol; 2006 Sep; 29(3):625-35. PubMed ID: 16865278
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antitumor evaluation of novel hybrids of phenylsulfonylfuroxan and epiandrosterone/dehydroepiandrosterone derivatives.
Huang Y; Liu M; Meng L; Feng P; Guo Y; Ying M; Zhu X; Chen Y
Steroids; 2015 Sep; 101():7-14. PubMed ID: 26004429
[TBL] [Abstract][Full Text] [Related]
36. Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
Bao N; Ou J; Xu M; Guan F; Shi W; Sun J; Chen L
Eur J Med Chem; 2017 Sep; 137():88-95. PubMed ID: 28558333
[TBL] [Abstract][Full Text] [Related]
37. Serum response factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6.
Farra R; Dapas B; Pozzato G; Giansante C; Heidenreich O; Uxa L; Zennaro C; Guarnieri G; Grassi G
Biochimie; 2010 May; 92(5):455-63. PubMed ID: 20144681
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological activity of glycyrrhetinic acid derivatives as antitumor agents.
Zhou F; Wu GR; Cai DS; Xu B; Yan MM; Ma T; Guo WB; Zhang WX; Huang XM; Jia XH; Yang YQ; Gao F; Wang PL; Lei HM
Eur J Med Chem; 2019 Sep; 178():623-635. PubMed ID: 31226654
[TBL] [Abstract][Full Text] [Related]
39. [Effects of nitric oxide on mitochondrial permeability transition and cytochrome C of human hepatocellular carcinoma cell lines].
Jiang XM; Zheng DL; Lin JY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Oct; 26(5):519-23. PubMed ID: 15562764
[TBL] [Abstract][Full Text] [Related]
40. Design and Synthesis of New Anticancer Glycyrrhetinic Acids and Oleanolic Acids.
Wang R; Zheng QX; Wang W; Feng L; Li HJ; Huai QY
Biol Pharm Bull; 2017; 40(5):703-710. PubMed ID: 28458357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
